Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2019 Dec 17;19(3):731–741. doi: 10.1158/1535-7163.MCT-19-0809

Figure 3. Unlike silvestrol, DDR and Roc inhibits proliferation of MDR1-overexpressing 697-R leukemic cells at IC50 values similar to parental 697 cells.

Figure 3.

Cell proliferation was measured on 697-R and 697 cells treated for 3 days with various concentrations of silvestrol (A), DDR (B), and Roc (C). Each treatment was performed in six replicates, and each experiment was repeated twice. Shown are representative dose-response growth inhibition curves for all three drugs from experiments run in parallel. The insets show the IC50 values for each compound.